These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19211850)

  • 1. Understanding the delayed onset of action of azathioprine in IBD: are we there yet?
    Atreya I; Neurath MF
    Gut; 2009 Mar; 58(3):325-6. PubMed ID: 19211850
    [No Abstract]   [Full Text] [Related]  

  • 2. Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines.
    Ben-Horin S; Goldstein I; Fudim E; Picard O; Yerushalmi Z; Barshack I; Bank I; Goldschmid Y; Meir SB; Mayer L; Chowers Y
    Gut; 2009 Mar; 58(3):396-403. PubMed ID: 18832521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of azathioprine products.
    Baker DE
    Rev Gastroenterol Disord; 2003; 3(4):219-23. PubMed ID: 14668694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications.
    Atreya I; Neurath MF
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):23-34. PubMed ID: 19072367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine treatment during lactation.
    Christensen LA; Dahlerup JF; Nielsen MJ; Fallingborg JF; Schmiegelow K
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1209-13. PubMed ID: 18761704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic inflammatory bowel diseases. Immunosuppressive drug saves on corticoids].
    MMW Fortschr Med; 1999 Sep; 141(38):55. PubMed ID: 10904620
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing the therapeutic potential of azathioprine/6-mercaptopurine in the treatment of inflammatory bowel disease.
    Papadakis KA
    J Clin Gastroenterol; 2003; 36(5):379-81. PubMed ID: 12702974
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive agents: Imurel and Purinethol].
    Groupe d'étude thérapeutique des affections inflammatoires digestives
    Rev Prat; 2005 May; 55(9):994. PubMed ID: 16052970
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment.
    Steel AW; Mela CM; Lindsay JO; Gazzard BG; Goodier MR
    Aliment Pharmacol Ther; 2011 Jan; 33(1):115-26. PubMed ID: 21083588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.
    Atreya R; Atreya I; Neurath MF
    Ann N Y Acad Sci; 2006 Aug; 1072():98-113. PubMed ID: 17057193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: Reproduction in the patient with inflammatory bowel disease.
    Heetun ZS; Byrnes C; Neary P; O'Morain C
    Aliment Pharmacol Ther; 2007 Aug; 26(4):513-33. PubMed ID: 17661756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
    Mudter J; Neurath MF
    Gut; 2007 Feb; 56(2):293-303. PubMed ID: 16956919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
    Rogler G
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
    [No Abstract]   [Full Text] [Related]  

  • 15. Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity.
    McGovern DP; Travis SP; Duley J; Shobowale-Bakre el M; Dalton HR
    Gastroenterology; 2002 Mar; 122(3):838-9. PubMed ID: 11878296
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: TPMT activity and age in IBD patients.
    Stocco G; De Iudicibus S; Cuzzoni E; Decorti G; Martelossi S; Ventura A
    Aliment Pharmacol Ther; 2012 Apr; 35(8):966-7; author reply 967-9. PubMed ID: 22436044
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory bowel disease.
    Stocco G; Decorti G; Bartoli F; Martelossi S; Ventura A
    Lancet; 2007 Jul; 370(9584):316-7. PubMed ID: 17662875
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressors for inflammatory bowel disease: how long is long enough?
    Modigliani R
    Inflamm Bowel Dis; 2000 Aug; 6(3):251-7; discussion 158. PubMed ID: 10961598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
    Sokol H; Beaugerie L
    Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for azathioprine treatment in inflammatory bowel disease].
    Cabré E
    Gastroenterol Hepatol; 2002 May; 25(5):319-26. PubMed ID: 11985804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.